Trustmark Corp (TRMK) concluded trading on Thursday at a closing price of $32.75, with 0.46 million shares of worth about $14.97 million changed hands on the day. Half year performance of the stock remained negative as price took a plunge of -5.07% during that period and on April 17, 2025 the price saw a gain of about 0.86%. Currently the company’s common shares owned by public are about 61.01M shares, out of which, 55.85M shares are available for trading.
Stock saw a price change of 5.27% in past 5 days and over the past one month there was a price change of -4.88%. Year-to-date (YTD), TRMK shares are showing a performance of -7.41% which increased to 27.78% when we look at its performance for past 12 months. Over the period of past 52 weeks, stock dropped to lowest price of $25.41 but also hit the highest price of $40.73 during that period. The average intraday trading volume for Trustmark Corp shares is 337.83K. The stock is currently trading -0.97% below its 20-day simple moving average (SMA20), while that difference is down -5.85% for SMA50 and it goes to -5.05% lower than SMA200.
Trustmark Corp (NASDAQ: TRMK) currently have 61.01M outstanding shares and institutions hold larger chunk of about 72.83% of that.
The stock has a current market capitalization of $1.99B and its 3Y-monthly beta is at 0.62. It has posted earnings per share of -$0.09 in the same period. It has a debt-to-equity ratio of 0.43. Volatility of a stock is a metric used to know how much the price of that stock is under influence and for TRMK, volatility over the week remained 3.42% while standing at 4.43% over the month.
Stock’s fiscal year EPS is expected to rise by 10.47% while it is estimated to increase by 4.67% in next year.
Digging deeper we find that several firms have released their research notes about the support levels of the stock. Most recent of them is a note released by Janney on January 24, 2025 offering a Buy rating for the stock and assigned a target price of $42 to it. Coverage by Hovde Group stated Trustmark Corp (TRMK) stock as a Market perform in their note to investors on October 29, 2024, suggesting a price target of $37 for the stock. Stock get an Outperform rating from Raymond James on February 21, 2023.
